Advertisement

Pneumonie

  • Michael Fresenius
  • Michael Heck

Zusammenfassung

Die maximale Inzidenz von ventilatorassoziierter Pneumonie (VAP) liegt nach Ibrahim et al. (2001) zwischen dem 6. und dem 10. Tag (◘ Abb. 13.1).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Ausgewählte Literatur

  1. Afessa B et al. (2006) Bronchoscopy in Ventilator-associated Pneumonia: Agreement of Calibrated Loop and Serial Dilution. Am J Respir Crit Care Med 173: 1229–1232PubMedCrossRefGoogle Scholar
  2. American Thoracic Society (ATS) (1996) Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity initial antimicrobial therapy and preventative strategies. Am J Respir Crit Care Med 153:1711–1725Google Scholar
  3. American Thoracic Society (ATS) (2001) Guidelines for the management of adults with community-acquired Pneumonia. Am J Crit Care Med 163:1730–1754Google Scholar
  4. American Thoracic Society (ATS) (2005) Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia Am J Resp Crit Care Med 171:388–416CrossRefGoogle Scholar
  5. Baughman RP (2000) Protected-specimen brush technique in the diagnosis of ventilator-associated pneumonia. Chest 117 (Suppl):203–206CrossRefGoogle Scholar
  6. Brodman KF et al. (2003) Nosokomiale Pneumonie: Prävention, Diagnostik und Therapie. Chemother J 12:33–44Google Scholar
  7. Brun-Buisson C (2007) Preventing ventilator associated pneumonia. BMJ 334: 861–862PubMedCrossRefGoogle Scholar
  8. Campbell GD (2000) Blinded invasive diagnostic procedures in ventilator-associated pneumonia. Chest 117: 207–211CrossRefGoogle Scholar
  9. Chastre J et al. and the Canadian Critical Care Trials Group (2007) Diagnosis of Ventilator-Associated Pneumonia. N Engl J Med 356: 1469–1471PubMedCrossRefGoogle Scholar
  10. Confalonerie M et al. (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248CrossRefGoogle Scholar
  11. Crist-Crain M et al. (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600–607CrossRefGoogle Scholar
  12. Cook DJ et al for the Canadian Critical Care Trials Group (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129:433–440PubMedGoogle Scholar
  13. Cook D, Mandell L (2000) Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest 117: 195–197CrossRefGoogle Scholar
  14. De Roux A, Marcos MA, Garcia E, Mensa J, Ewig S, Lode H, Torres A (2004) Viral community-acquired pneumonia in nonimmunocompromised adults. Chest 125:1343–1351PubMedCrossRefGoogle Scholar
  15. Ewig S et al. (2004) Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 59: 421–427PubMedCrossRefGoogle Scholar
  16. Fabregas N et al. (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54: 867–873PubMedCrossRefGoogle Scholar
  17. Fagon JY et al. (2000) Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 132: 621–630PubMedGoogle Scholar
  18. Fine MJ et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. NEJM 336:243–250PubMedCrossRefGoogle Scholar
  19. Francioli P, Chastre J, Langer M, Santos JI, Shah PM, Torres A (1997) Ventilator-associated pneumonia – understanding epidemiology and pathogenesis to guide prevention and empiric therapy. Clin Microb Infect 3 (Suppl):61–73CrossRefGoogle Scholar
  20. Gibot S et al. (2004) Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350: 451–458PubMedCrossRefGoogle Scholar
  21. Heyland DK, Cook DJ, Griffith L et al. for the Canadian Critical Care Trial Group (1999) The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 159:1249–1256PubMedGoogle Scholar
  22. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH (2001) The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 120:555–561PubMedCrossRefGoogle Scholar
  23. Ibrahim EH, Ward S, Sherman G, Kollef MH (2000) A comparative analysis of patients with early-onset vs lateonset nosocomial pneumonia in the ICU setting. Chest 117:1434–1442PubMedCrossRefGoogle Scholar
  24. Ibrahim et al. (2001) Experience with a clinical guideline fort he treatment of ventilator associated pneumonia. Crit Care Med 29:1109–1115PubMedCrossRefGoogle Scholar
  25. Keeley D et al. (2002) Guidelines for managing community acquired pneumonia in adults. BMJ 324:436–437PubMedCrossRefGoogle Scholar
  26. Kollef MH (2006) Diagnosis of Ventilator-Associated Pneumonia. N Engl J Med 355: 2691–2693PubMedCrossRefGoogle Scholar
  27. Lode H (2000) Nosokomiale Pneumonie. Internist 41:1170–79PubMedCrossRefGoogle Scholar
  28. Lode H, Schaberg T (1997) Therapie der nosokomialen Pneumonie. Dtsch Med Wochenschr 122: 93–96PubMedCrossRefGoogle Scholar
  29. Marquette CH et al. (1993) Diagnosis of pneumonia in mechanically ventilated patients: repeatibility of the protected specimen brush. Am Rev Respir Dis 147: 211–214PubMedCrossRefGoogle Scholar
  30. Neue Richtlinien zur Therapie der nosokomialen Pneumonie (2005) Z Chemother 17–20Google Scholar
  31. Pravention der nosokomialen Pneumonie (2000) Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 43:302–309CrossRefGoogle Scholar
  32. Pugin J et al. (1991) Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic »blind« bronchoalveolar lavage fluid. Am Rev Respir Dis 143: 1121–1129PubMedGoogle Scholar
  33. Rello J et al. (2001) International conference for the development of ventilator-associated pneumonia. Chest 120:955–970PubMedCrossRefGoogle Scholar
  34. Schaberg T, Lode H (1997) Diagnostik der nosokomialen Pneumonie. Dtsch Med Wochenschr 122: 61–64PubMedCrossRefGoogle Scholar
  35. Shorr AF et al. (2005) Invasive approaches to the diagnosis of ventilator-associated pneumonia: A meta-analysis. Critical Care Med 33: 46–53CrossRefGoogle Scholar
  36. Singh N et al. (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for discriminate antibiotic prescription. Am J Respir Crit Care Med 162:505–511PubMedGoogle Scholar
  37. Silber SH et al. (2003) Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest 124:1798–1804PubMedCrossRefGoogle Scholar
  38. Torres A, El-Ebiary M (2000) Bronchoscopic BAL in the diagnosis of ventilator associated pneumonia. Chest 117 (Suppl): 198–202CrossRefGoogle Scholar
  39. Torres A et al. (2001) Ventilator-associated pneumonia. European Task force on ventilator-associated pneumonia. Eur Respir J 17:1034–1045PubMedCrossRefGoogle Scholar
  40. Woodhead M et al. (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26: 1138–1180PubMedCrossRefGoogle Scholar
  41. Zack JE et al. (2002) Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 30: 2407–2412PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Michael Fresenius
    • 1
  • Michael Heck
    • 2
  1. 1.Chefarzt der Klinik für Anästhesie und IntensivmedizinMarienhaus Klinikum Bendorf-Neuwied-WaldbreitbachNeuwied
  2. 2.Facharzt für Anästhesiologie – ambulante Narkosen –Heidelberg

Personalised recommendations